These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37856934)

  • 41. Insulin resistance and inflammation mediate the association of abdominal obesity with colorectal cancer risk.
    Li W; Liu T; Qian L; Wang Y; Ma X; Cao L; Zhang Q; Qu J
    Front Endocrinol (Lausanne); 2022; 13():983160. PubMed ID: 36407320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review.
    Haram A; Boland MR; Kelly ME; Bolger JC; Waldron RM; Kerin MJ
    J Surg Oncol; 2017 Mar; 115(4):470-479. PubMed ID: 28105646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CIRCULATING GHRELIN LEVELS AND SUSCEPTIBILITY TO COLORECTAL CÂNCER.
    Asadi A; Farahani H; Mahmoudi T; Tabaeian SP; Rezamand G; Mohammadbeigi A; Dabiri R; Nobakht H; Rezvan S; Mohammadi F
    Arq Gastroenterol; 2021; 58(3):316-321. PubMed ID: 34705965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer.
    Liou JM; Shun CT; Liang JT; Chiu HM; Chen MJ; Chen CC; Wang HP; Wu MS; Lin JT
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1717-25. PubMed ID: 20157191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.
    Toiyama Y; Takahashi M; Hur K; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    J Natl Cancer Inst; 2013 Jun; 105(12):849-59. PubMed ID: 23704278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis.
    Wang SY; Zhang WS; Jiang CQ; Jin YL; Zhu T; Zhu F; Xu L
    Diabetes Metab J; 2024 Jan; 48(1):134-145. PubMed ID: 38173369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between markers of glucose metabolism and risk of colorectal cancer.
    Xu J; Ye Y; Wu H; Duerksen-Hughes P; Zhang H; Li P; Huang J; Yang J; Wu Y; Xia D
    BMJ Open; 2016 Jun; 6(6):e011430. PubMed ID: 27354075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between systemic inflammation and water composition and survival in colorectal cancer.
    Lin SQ; Xie HL; Ge YZ; Ruan GT; Zhang Q; Song MM; Zhang HY; Zhang X; Li XR; Tang M; Shen X; Song CH; Li W; Shi HP
    Front Oncol; 2022; 12():896160. PubMed ID: 36353554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative inflammation and nutrition-based comprehensive biomarker for predicting prognosis in resectable colorectal cancer.
    Cai H; Li J; Chen Y; Zhang Q; Liu Y; Jia H
    Front Oncol; 2023; 13():1279487. PubMed ID: 38074640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Log odds of positive lymph nodes as a novel prognostic predictor for colorectal cancer: a systematic review and meta-analysis.
    Li Y; Wu G; Zhang Y; Han B; Yang W; Wang X; Duan L; Niu L; Chen J; Zhou W; Liu J; Fan D; Hong L
    BMC Cancer; 2022 Mar; 22(1):290. PubMed ID: 35303818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive prognostic effects of systemic inflammation and Insulin resistance in women with breast cancer with different BMI: a prospective multicenter cohort.
    Ruan GT; Xie HL; Hu CL; Liu CA; Zhang HY; Zhang Q; Wang ZW; Zhang X; Ge YZ; Lin SQ; Tang M; Song MM; Zhang XW; Liu XY; Zhang KP; Yang M; Yu KY; Wang KH; Hu W; Deng L; Cong MH; Shi HP
    Sci Rep; 2023 Mar; 13(1):4303. PubMed ID: 36922570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of inflammation-based indexes in patients with stage III/IV colorectal cancer after adjuvant chemoradiotherapy.
    Yang J; Guo X; Wu T; Niu K; Ma X
    Medicine (Baltimore); 2019 Feb; 98(6):e14420. PubMed ID: 30732196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin Resistance and Colorectal Cancer Risk: the Role of Elevated Plasma Resistin Levels.
    Farahani H; Mahmoudi T; Asadi A; Nobakht H; Dabiri R; Hamta A
    J Gastrointest Cancer; 2020 Jun; 51(2):478-483. PubMed ID: 31168777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accuracy of isolated nutrition indicators in diagnosing malnutrition and their prognostic value to predict death in patients with gastric and colorectal cancer: A prospective study.
    de Sousa IM; Silva FM; de Carvalho ALM; da Rocha IMG; Fayh APT
    JPEN J Parenter Enteral Nutr; 2022 Mar; 46(3):508-516. PubMed ID: 34036614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer.
    Kubo H; Murayama Y; Arita T; Kuriu Y; Nakanishi M; Otsuji E
    World J Surg; 2016 Nov; 40(11):2796-2802. PubMed ID: 27307087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive comparative analysis of prognostic value of serum systemic inflammation biomarkers for colorectal cancer: Results from a large multicenter collaboration.
    Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Song M; Zhang X; Liu X; Lin S; Yang M; Hu C; Tang M; Deng L; Hu W; Shi H
    Front Immunol; 2022; 13():1092498. PubMed ID: 36685502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.
    You J; Zhu GQ; Xie L; Liu WY; Shi L; Wang OC; Huang ZH; Braddock M; Guo GL; Zheng MH
    Oncotarget; 2016 May; 7(18):25516-27. PubMed ID: 27027440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutrophil-lymphocyte ratio and nutritional status are clinically useful in predicting prognosis in colorectal cancer patients.
    Silva TH; Schilithz AOC; Peres WAF; Murad LB
    Nutr Cancer; 2020; 72(8):1345-1354. PubMed ID: 31665931
    [No Abstract]   [Full Text] [Related]  

  • 60. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
    Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.